These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15069135

  • 1. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients.
    Saltzman CL, Rashid R, Hayes A, Fellner C, Fitzpatrick D, Klapach A, Frantz R, Hillis SL.
    J Bone Joint Surg Am; 2004 Apr; 86(4):717-23. PubMed ID: 15069135
    [Abstract] [Full Text] [Related]

  • 2. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
    McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK.
    Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
    [Abstract] [Full Text] [Related]

  • 3. Sensory thresholds of normal human feet.
    Jeng C, Michelson J, Mizel M.
    Foot Ankle Int; 2000 Jun; 21(6):501-4. PubMed ID: 10884110
    [Abstract] [Full Text] [Related]

  • 4. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG.
    Arch Intern Med; 1998 Feb 09; 158(3):289-92. PubMed ID: 9472210
    [Abstract] [Full Text] [Related]

  • 5. Testing for loss of protective sensation in patients with foot ulceration: a cross-sectional study.
    Wood WA, Wood MA, Werter SA, Menn JJ, Hamilton SA, Jacoby R, Dellon AL.
    J Am Podiatr Med Assoc; 2005 Feb 09; 95(5):469-74. PubMed ID: 16166466
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
    Adams OP, Herbert JR, Howitt C, Unwin N.
    Diabet Med; 2019 Dec 09; 36(12):1629-1636. PubMed ID: 31094005
    [Abstract] [Full Text] [Related]

  • 7. Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
    Armstrong DG, Hussain SK, Middleton J, Peters EJ, Wunderlich RP, Lavery LA.
    Ostomy Wound Manage; 1998 May 09; 44(5):70-4, 76. PubMed ID: 9697548
    [Abstract] [Full Text] [Related]

  • 8. Mobile phone generated vibrations used to detect diabetic peripheral neuropathy.
    May JD, Morris MWJ.
    Foot Ankle Surg; 2017 Dec 09; 23(4):281-284. PubMed ID: 29202988
    [Abstract] [Full Text] [Related]

  • 9. Pilot study on the significance of random intrasite placement of the Semmes-Weinstein monofilament.
    Slater RA, Koren S, Ramot Y, Buchs A, Rapoport MJ.
    Diabetes Metab Res Rev; 2013 Mar 09; 29(3):235-8. PubMed ID: 23283830
    [Abstract] [Full Text] [Related]

  • 10. Interpreting the results of the Semmes-Weinstein monofilament test: accounting for false-positive answers in the international consensus on the diabetic foot protocol by a new model.
    Slater RA, Koren S, Ramot Y, Buchs A, Rapoport MJ.
    Diabetes Metab Res Rev; 2014 Jan 09; 30(1):77-80. PubMed ID: 23996640
    [Abstract] [Full Text] [Related]

  • 11. The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot.
    Papanas N, Gries A, Maltezos E, Zick R.
    Diabetologia; 2006 Apr 09; 49(4):739-43. PubMed ID: 16425034
    [Abstract] [Full Text] [Related]

  • 12. Intravenous angiocatheters as a novel alternative to Semmes-Weinstein monofilament evaluation in testing protective sensation.
    Hire JM, Ramadorai UE, Contractor D, Jacobs JM, Bojescul JA, Abell BE.
    Mil Med; 2014 Apr 09; 179(4):442-4. PubMed ID: 24690970
    [Abstract] [Full Text] [Related]

  • 13. Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research.
    Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL.
    J Gen Intern Med; 1999 Jul 09; 14(7):418-24. PubMed ID: 10417599
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, Watanabe H, Fujikawa R, Okubo M, Kohno N.
    J Diabetes Complications; 2005 Jul 09; 19(1):47-53. PubMed ID: 15642490
    [Abstract] [Full Text] [Related]

  • 15. Site-Specific, Critical Threshold Barefoot Peak Plantar Pressure Associated with Diabetic Foot Ulcer History: A Novel Approach to Determine DFU Risk in the Clinical Setting.
    Abbott CA, Chatwin KE, Rajbhandari SM, John KM, Pabbineedi S, Bowling FL, Boulton AJM, Reeves ND.
    Medicina (Kaunas); 2022 Jan 21; 58(2):. PubMed ID: 35208490
    [Abstract] [Full Text] [Related]

  • 16. Role of neuropathy and high foot pressures in diabetic foot ulceration.
    Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A.
    Diabetes Care; 1998 Oct 21; 21(10):1714-9. PubMed ID: 9773736
    [Abstract] [Full Text] [Related]

  • 17. Reliability and responsiveness of an 18 site, 10-g monofilament examination for assessment of protective foot sensation.
    Young D, Schuerman S, Flynn K, Hartig K, Moss D, Altenburger B.
    J Geriatr Phys Ther; 2011 Oct 21; 34(2):95-8. PubMed ID: 21937899
    [Abstract] [Full Text] [Related]

  • 18. Predicting ulcer-free survival using the discriminative value of screening test locations.
    Rinkel WD, van der Oest MJW, Dijkstra DA, Castro Cabezas M, Coert JH.
    Diabetes Metab Res Rev; 2019 Mar 21; 35(3):e3119. PubMed ID: 30575290
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility.
    Miranda-Palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJ.
    Diabetes Res Clin Pract; 2005 Oct 21; 70(1):8-12. PubMed ID: 16126117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.